Ilagan; Roger M.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Ilagan; Roger M..The latest application filed is for "treatment of vasculopathy with prostacyclin and mesenchymal stem cells".
- Ilagan; Roger M. - Burlington NC
| Patent | Date |
|---|---|
| Treatment Of Vasculopathy With Prostacyclin And Mesenchymal Stem Cells App 20220062210 - Jeffs; Roger ; et al. | 2022-03-03 |
| Treatment of vasculopathy with prostacyclin and mesenchymal stem cells Grant 11,141,393 - Jeffs , et al. October 12, 2 | 2021-10-12 |
| Bioactive Renal Cells App 20210238600 - Bertram; Timothy A. ; et al. | 2021-08-05 |
| Bioactive renal cells Grant 11,066,666 - Bertram , et al. July 20, 2 | 2021-07-20 |
| Treatment Of Pulmonary Arterial Hypertension With Prostacyclin-treated Endothelial Progenitor Cells App 20210030812 - Jeffs; Roger ; et al. | 2021-02-04 |
| Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cells Grant 10,842,823 - Jeffs , et al. November 24, 2 | 2020-11-24 |
| Treatment Of Vasculopathy With Prostacyclin And Mesenchymal Stem Cells App 20190160032 - Jeffs; Roger ; et al. | 2019-05-30 |
| Isolated Renal Cells And Uses Thereof App 20190117695 - Presnell; Sharon C. ; et al. | 2019-04-25 |
| Treatment Of Pulmonary Arterial Hypertension With Mesenchymal Stem Cells App 20190008904 - Jeffs; Roger ; et al. | 2019-01-10 |
| Isolated renal cells and uses thereof Grant 10,105,392 - Presnell , et al. October 23, 2 | 2018-10-23 |
| Treatment Of Pulmonary Arterial Hypertension With Prostacyclin-treated Endothelial Progenitor Cells App 20180280445 - Jeffs; Roger ; et al. | 2018-10-04 |
| Bioactive Renal Cells App 20180282726 - Bertram; Timothy A. ; et al. | 2018-10-04 |
| Treatment of vasculopathy with prostacyclin and mesenchymal stem cells Grant 10,080,730 - Jeffs , et al. September 25, 2 | 2018-09-25 |
| Bioactive renal cells Grant 10,077,442 - Bertram , et al. September 18, 2 | 2018-09-18 |
| Treatment of pulmonary arterial hypertension with mesenchymal stem cells Grant 10,071,123 - Jeffs , et al. September 11, 2 | 2018-09-11 |
| Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cells Grant 10,016,463 - Jeffs , et al. July 10, 2 | 2018-07-10 |
| Cell Scaffold Constructs App 20180071074 - Ludlow; John W. ; et al. | 2018-03-15 |
| Bioactive Renal Cells App 20160244751 - ILAGAN; Roger M. | 2016-08-25 |
| Isolated Renal Cells And Uses Thereof App 20160206659 - Presnell; Sharon C. ; et al. | 2016-07-21 |
| Cell scaffold constructs Grant 9,271,824 - Ludlow , et al. March 1, 2 | 2016-03-01 |
| Isolated renal cells and uses thereof Grant 9,192,629 - Presnell , et al. November 24, 2 | 2015-11-24 |
| Treatment Of Pulmonary Arterial Hypertension With Mesenchymal Stem Cells App 20150246078 - Jeffs; Roger ; et al. | 2015-09-03 |
| Treatment Of Pulmonary Arterial Hypertension With Prostacyclin-treated Endothelial Progenitor Cells App 20150216909 - Jeffs; Roger ; et al. | 2015-08-06 |
| Smooth Muscle Cell Constructs App 20150030657 - Ludlow; John W. ; et al. | 2015-01-29 |
| Treatment Of Vasculopathy With Prostacyclin And Mesenchymal Stem Cells App 20140193379 - Jeffs; Roger ; et al. | 2014-07-10 |
| Cell Scaffold Constructs App 20130173015 - Ludlow; John W. ; et al. | 2013-07-04 |
| Isolated Renal Cells And Uses Thereof App 20130149347 - Presnell; Sharon C. ; et al. | 2013-06-13 |
| Cell-scaffold constructs Grant 8,337,485 - Ludlow , et al. December 25, 2 | 2012-12-25 |
| Isolated renal cells and uses thereof Grant 8,318,484 - Presnell , et al. November 27, 2 | 2012-11-27 |
| Rational Design Of Regenerative Medicine Products App 20110123455 - Presnell; Sharon C. ; et al. | 2011-05-26 |
| Isolated Renal Cells and Uses Thereof App 20110117162 - Presnell; Sharon C. ; et al. | 2011-05-19 |
| Cell-Scaffold Constructs App 20100131075 - Ludlow; John W. ; et al. | 2010-05-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 